Nan Fung Trinity’s Viavi Solutions VIAV Stock Holding History

Nan Fung Trinity’s Portfolio VIAV Stock Details VIAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-22,540	Closed	-$353K	–	43
2021 Q1	$353K	Hold	22,540	–	–	0.08%	37
2020 Q4	$337K	Hold	22,540	–	–	0.06%	40
2020 Q3	$264K	Hold	22,540	–	–	0.05%	55
2020 Q2	$287K	Buy	+22,540	New	+$270K	0.06%	63

Other funds holding VIAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nan Fung Trinity's VIAV Position: Q2 2021 in Review

Nan Fung Trinity sold out of Viavi Solutions (VIAV) in Q2 2021, closing a stake of 22,540 shares — an estimated $353K sold.

Nan Fung Trinity first reported a position in VIAV in Q2 2020 and held it in 4 quarters. The position peaked at $353K in Q1 2021. 291 funds tracked by Wall St. Rank hold VIAV as of Q2 2021.

Nan Fung Trinity reported no remaining Viavi Solutions position as of Q2 2021 after selling out during the quarter.
Nan Fung Trinity sold 22,540 Viavi Solutions shares in Q2 2021, an estimated $353K.
Nan Fung Trinity first reported a position in Viavi Solutions in Q2 2020 and held it in 4 quarters.
Nan Fung Trinity's Viavi Solutions position peaked at $353K in Q1 2021.
291 funds tracked by Wall St. Rank held Viavi Solutions as of Q2 2021.

Based on Nan Fung Trinity's 13F filing for Q2 2021, filed 4 Aug 2021.